Functional consequence of targeting protein kinase B/Akt to GLUT4 vesicles

J Cell Sci. 2002 Jul 15;115(Pt 14):2857-66. doi: 10.1242/jcs.115.14.2857.

Abstract

We have investigated the role of protein kinase B (Akt) in the insulin-stimulated translocation of vesicles containing the insulin-responsive isoform of glucose transporter (GLUT4) to the plasma membrane of adipocytes. Previous reports have suggested that protein kinase B can bind to intracellular GLUT4 vesicles in an insulin-dependent manner, but the functional consequence of this translocation is not known. In this study we have artificially targeted constitutively active and kinase-inactive mutants of protein kinase B to intracellular GLUT4 vesicles by fusing them with the N-terminus of GLUT4 itself. We examined the effect of these mutants on the insulin-dependent translocation of the insulin-responsive amino peptidase IRAP (a bona fide GLUT4-vesicle-resident protein). A kinase-inactive protein kinase B targeted to GLUT4 vesicles was an extremely effective dominant-negative inhibitor of insulin-stimulated IRAP translocation to the plasma membrane. By contrast, a kinase-inactive protein kinase B expressed in the cytoplasm did not have an effect. The results suggest that protein kinase B has an important functional role at, or in the vicinity of, GLUT4 vesicles in the insulin-dependent translocation of those vesicles to the plasma membrane of adipocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Aminopeptidases / drug effects
  • Aminopeptidases / genetics
  • Aminopeptidases / metabolism
  • Animals
  • Biomarkers
  • Cell Compartmentation / drug effects
  • Cell Compartmentation / genetics
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Cell Membrane / ultrastructure
  • Cystinyl Aminopeptidase
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Glucose / metabolism
  • Glucose Transporter Type 4
  • Insulin / metabolism*
  • Insulin / pharmacology
  • Mice
  • Monosaccharide Transport Proteins / drug effects
  • Monosaccharide Transport Proteins / genetics
  • Monosaccharide Transport Proteins / metabolism*
  • Muscle Proteins*
  • Mutation / drug effects
  • Mutation / genetics
  • Protein Serine-Threonine Kinases*
  • Protein Structure, Tertiary / drug effects
  • Protein Structure, Tertiary / physiology
  • Protein Transport / drug effects
  • Protein Transport / physiology*
  • Proto-Oncogene Proteins / drug effects
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-akt
  • Recombinant Fusion Proteins / drug effects
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Transcription Factors / drug effects
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transport Vesicles / drug effects
  • Transport Vesicles / metabolism*
  • Transport Vesicles / ultrastructure

Substances

  • Biomarkers
  • DNA-Binding Proteins
  • Glucose Transporter Type 4
  • Insulin
  • Monosaccharide Transport Proteins
  • Muscle Proteins
  • Proto-Oncogene Proteins
  • Recombinant Fusion Proteins
  • Slc2a4 protein, mouse
  • Transcription Factors
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Aminopeptidases
  • Cystinyl Aminopeptidase
  • leucyl-cystinyl aminopeptidase
  • Glucose